Regen BioPharma Inc (RGBP)
0.675
+0.12
(+20.54%)
USD |
OTCM |
May 10, 16:00
Regen BioPharma Profit Margin (Quarterly): -207.4% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -207.4% |
| December 31, 2023 | -592.2% |
| September 30, 2023 | -472.1% |
| June 30, 2023 | -168.0% |
| March 31, 2023 | -93.08% |
| December 31, 2022 | |
| September 30, 2022 | -113.8% |
| June 30, 2022 | |
| March 31, 2022 | -114.9K% |
| December 31, 2021 | |
| September 30, 2021 | -2.32K% |
| June 30, 2021 | -13.22K% |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | -14.87K% |
| December 31, 2019 |
| Date | Value |
|---|---|
| September 30, 2019 | |
| June 30, 2019 | -16.08K% |
| March 31, 2019 | -1.22K% |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | -107.6% |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | -2.38K% |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | -993.1% |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | -273.8% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-114.9K%
Minimum
Mar 2022
-93.08%
Maximum
Mar 2023
-14.82K%
Average
-592.2%
Median
Dec 2023
Profit Margin (Quarterly) Benchmarks
| AIM ImmunoTech Inc | -19.35K% |
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | -57.64% |
| Electromed Inc | 10.76% |
| Armata Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -362.8% |
| Operating Margin (Quarterly) | -171.1% |